Skip to content

Frances E. Broyles, MD

NPI 1669454583ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Seattle, WA

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Seattle, Washington, licensed in WA, with an NPI issued in November 2005. Eli Lilly and Company was the largest of 4 companies reporting payments in 2025, $2,684 in all, mostly travel and lodging.

Overview

NPI1669454583
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedNov 16, 2005
Last updated in NPPESJun 20, 2008

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary207RE0101XMD00027695WA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$2,684 · 25 payments from 4 companies
  • 2024$26.16 · 2 payments from 1 company

Top paying companies in 2025

What the 2025 payments were for

  • Travel and Lodging$2,271 · 16 payments
  • Food and Beverage$413.43 · 9 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Seattle

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Washington →